NAVCO Pharmaceuticals Inc (TSE:NAV) has released an update.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Navco Pharmaceuticals Inc. has been granted a Health Canada license for a nanoparticle-based antimicrobial cream, expanding their product range with a novel skin protection option. The cream, which uses nano-silver for its germ-fighting properties, offers moisturizing benefits and is an alcohol-free alternative to sprays. It aligns with the growing dermocosmetics market, which is projected to see significant growth over the next decade.
For further insights into TSE:NAV stock, check out TipRanks’ Stock Analysis page.